SFOSF

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. SFOSF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SFOSF BIOVF RCDTF CSPCY BDULF ESAIY ESALF BDUUF GIFLF ORINF
6M 41.33 % 30.27 % 0.00 % 6.71 % -1.61 % 7.48 % -1.06 % -1.67 % 1.83 % 67.11 %
YTD 53.89 % 24.56 % 17.82 % 90.78 % -28.24 % 8.43 % 5.45 % -23.38 % 22.09 % 67.11 %
1Y 55.62 % 27.44 % 25.24 % 80.61 % -28.24 % 8.75 % 13.10 % -23.38 % 22.09 % 67.11 %
3Y -12.34 % 66.67 % 61.98 % 1.78 % -29.89 % -52.77 % -54.31 % -34.59 % 9.28 % 101.79 %
5Y -44.60 % 82.36 % 23.73 % 13.00 % -9.06 % -52.77 % -58.57 % -20.27 % -59.92 % 86.72 %
10Y -4.15 % 82.36 % 154.63 % 48.38 % 1.67 % -52.77 % -55.04 % -8.24 % -48.75 % 133.35 %
From the beginning -18.29 % 82.36 % 709.90 % 48.38 % 388.00 % -52.77 % 43.64 % 883.33 % -99.94 % 228.48 %

Dividend

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Recordati Industria Chimica e Farmaceutica S.p.A.

CSPC Pharmaceutical Group Limited

Bangkok Dusit Medical Services Public Company Limited

Eisai Co., Ltd.

Eisai Co., Ltd.

Bangkok Dusit Medical Services Public Company Limited

Grifols, S.A.

Orion Oyj